1. Home
  2. TSHA vs GTY Comparison

TSHA vs GTY Comparison

Compare TSHA & GTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.49

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Getty Realty Corporation

GTY

Getty Realty Corporation

HOLD

Current Price

$33.07

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSHA
GTY
Founded
2019
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2020
1998

Fundamental Metrics

Financial Performance
Metric
TSHA
GTY
Price
$5.49
$33.07
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
$11.63
$32.60
AVG Volume (30 Days)
2.0M
329.0K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
N/A
5.92%
EPS Growth
5.56
8.00
EPS
N/A
0.43
Revenue
$9,773,000.00
$221,727,000.00
Revenue This Year
N/A
$9.39
Revenue Next Year
$1,152.42
$7.83
P/E Ratio
N/A
$74.93
Revenue Growth
17.28
9.02
52 Week Low
$2.25
$25.39
52 Week High
$7.30
$34.75

Technical Indicators

Market Signals
Indicator
TSHA
GTY
Relative Strength Index (RSI) 43.87 54.82
Support Level $5.27 $32.44
Resistance Level $6.01 $33.99
Average True Range (ATR) 0.36 0.66
MACD -0.04 -0.02
Stochastic Oscillator 36.78 72.84

Price Performance

Historical Comparison
TSHA
GTY

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

About GTY Getty Realty Corporation

Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.

Share on Social Networks: